-
Morning Alert: General Electric Company (NYSE:GE), Sprint Corporation (NYSE:S), Valeant Pharmaceuticals Intl Inc (NYSE:VRX), Digirad Corporation (NASDAQ:DRAD), VeriFone Systems (NYSE:PAY)
General Electric Company (NYSE:GE) announced the opening of its new Advanced Manufacturing Lab (AML) in Plainville, CT. General Electric had earlier launched the NPI (New Product Introduction) Accelerator Lab in Plainville in May 2013. This AML is likely to further augment the development of new techniques and processes. General Electric Company (NYSE:GE) in last trading…
-
Morning Buzz: Intel Corporation (NASDAQ:INTC), Valeant Pharmaceuticals Intl Inc (NYSE:VRX), Netlist Inc. (NASDAQ:NLST), The Marcus Corporation (NYSE:MCS), Orion Marine Group, Inc (NYSE:ORN)
World’s largest chipmaker Intel Corporation (NASDAQ:INTC) has unveiled the Intel Sensing Platform for enabling mobile-based healthcare delivery to masses. “Our new chip, combining hardware, mobility, analytics and cloud-based technology enables doctors and hospitals to provide affordable personal healthcare for masses,” the US-based company’s Indian subsidiary said in a statement in Bangalore on Monday. Intel Corporation…
-
Watch List: Nabors Industries (NYSE:NBR), Valeant Pharmaceuticals Intl Inc (NYSE:VRX), Pfizer Inc. (NYSE:PFE), Hooper Holmes Inc. (NYSEMKT:HH), Citigroup Inc. (NYSE:C)
Nabors Industries Ltd (NYSE:NBR) declared a quarterly dividend on Tuesday, October 28th, AnalystRatings.NET reports. Shareholders of record on Wednesday, December 10th will be given a dividend of 0.06 per share on Wednesday, December 31st. This represents a $0.24 dividend on an annualized basis and a yield of 1.36%. The ex-dividend date of this dividend is…
-
Don’t Miss: Gilead Sciences Inc. (NASDAQ:GILD), Kinross Gold Corporation (NYSE:KGC), Valeant Pharmaceuticals Intl Inc (NYSE:VRX), Puma Biotechnology (NYSE:PBYI), Brookdale Senior Living (NYSE:BKD)
Gilead Sciences (NASDAQ:GILD) CEO John C. Martin sold 140,625 shares of the company’s stock in a transaction dated Monday, November 3rd. The stock was sold at an average price of $110.40, for a total transaction of $15,525,000.00. Gilead Sciences Inc. (NASDAQ:GILD) in last trading activity moved down -2.05% to close at $102.06. Company weekly performance…
-
Today’s Watch List: Portola Pharmaceuticals (NASDAQ:PTLA), Baxano Surgical (NASDAQ:BAXS), Buffalo Wild Wings Inc. (NASDAQ:BWLD), Valeant Pharmaceuticals (NYSE:VRX), AGCO Corporation (NYSE:AGCO)
On 10 November Portola Pharmaceuticals, Inc. (NASDAQ:PTLA) issued its quarterly earnings data on Monday. The company reported ($0.86) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.92) by $0.06. The company had revenue of $2.40 million for the quarter, compared to the consensus estimate of $2.73 million. During the same quarter…
-
Momentum Stocks: Cellular Dynamics International (NASDAQ:ICEL), General Electric Company (NYSE:GE), Franklin Street Properties (NYSEMKT:FSP), Grand Canyon Education (NASDAQ:LOPE), Valeant Pharmaceuticals (NYSE:VRX)
On October 29, The National Eye Institute has granted Cellular Dynamics International Inc. (NASDAQ:ICEL) a $1.2 million contract to manufacture clinically compatible induced pluripotent stem cells and induced pluripotent stem cell-derived human retinal pigment epithelial cells, according to a company press release. Cellular Dynamics International, Inc. (NASDAQ:ICEL) in last trading activity increased 0.68% to close…
-
Stocks in Focus: Citigroup Inc. (NYSE:C), ADTRAN Inc. (NASDAQ:ADTN), Pandora Media Inc (NYSE:P), Leading Brands Inc. (NASDAQ:LBIX), Valeant Pharmaceuticals Intl Inc (NYSE:VRX)
On 30 October Citigroup Inc. (NYSE:C) announced it has added $600 million to its legal provisions fund, on top of what had been kept aside in the third fiscal quarter. Citigroup Inc. (NYSE:C) in last trading activity increased 0.71% to close at $53.53. Company weekly performance is 3.36% while its quarterly performance stands at 10.76%.…
-
Morning Watch List: Schlumberger Limited (NYSE:SLB), Mondelez International(NASDAQ:MDLZ), South Jersey Industries(NYSE:SJI), Alnylam Pharmaceuticals (NASDAQ:ALNY), Valeant Pharmaceuticals Intl (NYSE:VRX)
Schlumberger Limited. (NYSE:SLB) Director Michael E. Marks bought 3,250 shares of the company’s stock in a transaction that occurred on Monday, October 27th. The stock was purchased at an average cost of $92.59 per share, for a total transaction of $300,917.50. Schlumberger Limited (NYSE:SLB) in last trading activity increased 3.20% to close at $96.51. Company…
-
Watch List: Eli Lilly and Co (NYSE:LLY), Valeant Pharmaceuticals Intl Inc (NYSE:VRX), Allergan, Inc. (NYSE:AGN), Samson Oil & Gas Limited (ADR) (NYSEMKT:SSN)
Eli Lilly and Co (NYSE:LLY) is making a bet on rising global demand for animal drugs and vaccines with a deal to acquire Novartis AG’s animal-health business for $5.4 billion. Lilly said the purchase would make its Elanco unit the second-biggest animal-health company by global revenue, behind Zoetis Inc., the company spun out by Pfizer…
-
Drug Stocks – Generex Biotechnology Corporation (OTCMKTS:GNBT), Delcath Systems, Inc. (NASDAQ:DCTH), Hospira, Inc. (NYSE:HSP), Valeant Pharmaceuticals Intl (NYSE:VRX)
Shares of Generex Biotechnology Corporation (OTCMKTS:GNBT) is a Canada-based Company, which develops drug delivery systems and technologies for the treatment of diabetes. The Company has developed a proprietary platform technology for the delivery of drugs into the human body through the oral cavity. Shares of Generex Biotechnology Corporation (OTCMKTS:GNBT) closed at $0.0513 in last trading…